Sangamo BioSciences, Inc. Announces Seven Data Presentations At The...

"In particular, and for the first time, we will provide details of our ZFP Therapeutic approach to the treatment of sickle cell disease and b-thalassemia.

http://www.biospace.com/news_story.aspx?StoryID=316542&full=1